COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 177 filers reported holding COHERUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,121,978 | -17.7% | 5,380,208 | -6.1% | 0.00% | -33.3% |
Q2 2023 | $24,462,481 | -40.2% | 5,728,918 | -4.2% | 0.00% | -40.0% |
Q1 2023 | $40,920,000 | +79328.5% | 5,982,535 | -8.0% | 0.01% | -28.6% |
Q4 2022 | $51,518 | -99.9% | 6,504,863 | +6.2% | 0.01% | -12.5% |
Q3 2022 | $58,864,000 | +25.4% | 6,125,245 | -5.6% | 0.01% | +14.3% |
Q2 2022 | $46,959,000 | -44.7% | 6,486,231 | -1.4% | 0.01% | -30.0% |
Q1 2022 | $84,890,000 | -20.5% | 6,575,543 | -1.7% | 0.01% | -16.7% |
Q4 2021 | $106,768,000 | -7.3% | 6,689,748 | -6.7% | 0.01% | -14.3% |
Q3 2021 | $115,236,000 | +36.7% | 7,170,867 | +17.7% | 0.01% | +40.0% |
Q2 2021 | $84,281,000 | +11.0% | 6,094,058 | +17.3% | 0.01% | 0.0% |
Q1 2021 | $75,915,000 | -11.8% | 5,196,106 | +4.9% | 0.01% | -23.1% |
Q4 2020 | $86,094,000 | -3.2% | 4,953,582 | +4.7% | 0.01% | -13.3% |
Q3 2020 | $88,977,000 | +9.8% | 4,730,357 | +4.2% | 0.02% | -6.2% |
Q2 2020 | $81,047,000 | +21.2% | 4,537,904 | +10.0% | 0.02% | 0.0% |
Q1 2020 | $66,896,000 | +7.5% | 4,124,245 | +19.3% | 0.02% | +33.3% |
Q4 2019 | $62,251,000 | -16.3% | 3,457,470 | -5.9% | 0.01% | -20.0% |
Q3 2019 | $74,408,000 | -18.8% | 3,672,646 | -13.9% | 0.02% | -16.7% |
Q2 2019 | $91,630,000 | +41.6% | 4,263,805 | -10.1% | 0.02% | +38.5% |
Q1 2019 | $64,689,000 | +91.5% | 4,742,589 | +27.1% | 0.01% | +62.5% |
Q4 2018 | $33,774,000 | -6.5% | 3,731,881 | +70.5% | 0.01% | +14.3% |
Q3 2018 | $36,107,000 | +15.5% | 2,188,328 | -2.0% | 0.01% | +16.7% |
Q2 2018 | $31,261,000 | +38.3% | 2,232,898 | +9.2% | 0.01% | +20.0% |
Q1 2018 | $22,598,000 | +33.4% | 2,045,068 | +6.3% | 0.01% | +25.0% |
Q4 2017 | $16,935,000 | -28.4% | 1,924,494 | +9.9% | 0.00% | -20.0% |
Q3 2017 | $23,640,000 | +18.4% | 1,751,202 | +25.8% | 0.01% | 0.0% |
Q2 2017 | $19,971,000 | -42.1% | 1,391,711 | -14.6% | 0.01% | -37.5% |
Q1 2017 | $34,485,000 | -21.7% | 1,630,487 | +4.2% | 0.01% | -27.3% |
Q4 2016 | $44,051,000 | -14.8% | 1,564,868 | -19.0% | 0.01% | -15.4% |
Q3 2016 | $51,712,000 | +63.1% | 1,930,979 | +2.9% | 0.01% | +62.5% |
Q2 2016 | $31,701,000 | -29.7% | 1,876,937 | -11.6% | 0.01% | -33.3% |
Q1 2016 | $45,062,000 | +18.5% | 2,122,551 | +28.2% | 0.01% | +20.0% |
Q4 2015 | $38,025,000 | +38.0% | 1,656,163 | +20.5% | 0.01% | +42.9% |
Q3 2015 | $27,554,000 | -37.5% | 1,374,970 | -9.8% | 0.01% | -30.0% |
Q2 2015 | $44,069,000 | +12.2% | 1,524,911 | +18.7% | 0.01% | +11.1% |
Q1 2015 | $39,285,000 | +227.3% | 1,284,703 | +74.7% | 0.01% | +200.0% |
Q4 2014 | $12,001,000 | – | 735,319 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |